Cargando…
Lercanidipine Synergistically Enhances Bortezomib Cytotoxicity in Cancer Cells via Enhanced Endoplasmic Reticulum Stress and Mitochondrial Ca(2+) Overload
The proteasome inhibitor (PI), bortezomib (Btz), is effective in treating multiple myeloma and mantle cell lymphoma, but not solid tumors. In this study, we show for the first time that lercanidipine (Ler), an antihypertensive drug, enhances the cytotoxicity of various PIs, including Btz, carfilzomi...
Autores principales: | Lee, A Reum, Seo, Min Ji, Kim, Jin, Lee, Dong Min, Kim, In Young, Yoon, Mi Jin, Hoon, Hur, Choi, Kyeong Sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941136/ https://www.ncbi.nlm.nih.gov/pubmed/31817163 http://dx.doi.org/10.3390/ijms20246112 |
Ejemplares similares
-
Release of Ca(2+) from the endoplasmic reticulum and its subsequent influx into mitochondria trigger celastrol-induced paraptosis in cancer cells
por: Yoon, Mi Jin, et al.
Publicado: (2014) -
Tauroursodeoxycholic acid (TUDCA) attenuates pressure overload-induced cardiac remodeling by reducing endoplasmic reticulum stress
por: Rani, Shilpa, et al.
Publicado: (2017) -
Ca(2+) influx-mediated dilation of the endoplasmic reticulum and c-FLIP(L) downregulation trigger CDDO-Me–induced apoptosis in breast cancer cells
por: Jeong, Soo Ah, et al.
Publicado: (2015) -
Sphingosine kinase 2 inhibition synergises with bortezomib to target myeloma by enhancing endoplasmic reticulum stress
por: Wallington-Beddoe, Craig T., et al.
Publicado: (2017) -
Lercanidipine in Hypertension
por: Borghi, Claudio
Publicado: (2005)